We’re Not Just Capturing Moments—We’re Interpreting Them For Action.

AI Vision:
From Concept to Reality
With nearly 10,000 bedside cameras deployed across 300+ hospitals, we have a unique infrastructure, allowing for swift development and efficient deployment of our AI models. This reach ensures AIVision can evolve through real-world scenarios, delivering value at scale.
We’re testing its motion analysis algorithms integrated within its existing camera infrastructure, laying the foundation for a suite of screening and decision-support applications.
Key to our AI strategy was the acquisition of the Early Detection Neuromotor Assessment (EDNA) platform which enables the training of video models to assist in identifying neuromotor risk factors, supporting earlier interventions.
Additional Areas Under Active Development
While many of these technologies are still under research and development and may require FDA clearance before clinical deployment, they represent the company’s broader vision and investment in a connected, intelligent NICU environment of the future, providing a richer understanding of pediatric health patterns over time.
Clinical Collaboration & Strategic Partnerships – Looking Ahead
AngelEye is currently working with several talented partners to make the vision of the intelligent pediatric unit a reality. We invite researchers, clinicians, and health systems to collaborate on next-generation tools and studies that will validate and expand the clinical utility of AI in pediatric units. These partnerships are key to ensuring ethical, evidence-based deployment of machine learning. If you are interested in accelerating the pediatric unit of the future together, please click the button below to connect with us.


Built on a Strong Foundation
EDNA’s algorithms and clinical service model have been developed in collaboration with leading scientists and hospitals, including Nationwide Children’s Hospital. Ongoing research is underway to validate further and discover additional sensor-based algorithms and services for newborns.
This page contains information about a medical device product that has not yet received clearance from the U.S. Food and Drug Administration (FDA). The product is currently undergoing the necessary regulatory review process, and its safety and efficacy have not yet been established. Any statements regarding the product’s potential benefits are based on preliminary data and are subject to change upon further evaluation and FDA approval.